Amglos Pharmaceutical Private Limited
About Amglos Pharmaceutical Private Limited
Data last updated:
Amglos Pharmaceutical Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2019PTC123757. Its GSTIN is 09AASCA9746Q1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandni Sharma and Garima Gautam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh No. 1319 Amar Vihar Behta Loni, Ghaziabad, Uttar Pradesh, India – 201102.
As per the financials filed for FY 2024, the company reported a revenue of ₹49.12 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹62,901 (net margin 1.3%) and EBITDA of ₹1.15 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
Company details
Contact details
Amglos Pharmaceutical Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressKh No. 1319 Amar Vihar Behta Loni, Ghaziabad, Uttar Pradesh, India – 201102
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Amglos Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amglos Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Amglos Pharmaceutical Private Limited, buy the company report.
Financials of Amglos Pharmaceutical Private Limited
FY 2025 filings availableAmglos Pharmaceutical Private Limited reported revenue of ₹49.12 Lakh (up 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 9% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62,901 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amglos Pharmaceutical Private Limited, buy the company report.
Board of directors of Amglos Pharmaceutical Private Limited
Amglos Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandni Sharma | Director | 25 Nov 2019 | 6 Years 10 Months | Current |
| Garima Gautam | Director | 25 Nov 2019 | 6 Years 10 Months | Current |
Peer comparison
Amglos Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| DVM Life Sciences Private Limited | ₹49.15 Lakh (FY 2025) | 40.0% | Kanpur, Uttar Pradesh, India | |||
| Nexgen Power Engitech Private Limited | ₹49.15 Lakh (FY 2025) | -98.0% | Bilaspur, Chhattisgarh, India | |||
| Zware Mercantile Private Limited | ₹49.14 Lakh (FY 2025) | 6.0% | Ludhiana, Punjab, India | |||
| Autopark India Motors Private Limited | ₹49.13 Lakh (FY 2024) | 436.0% | Thane, Maharashtra, India | |||
| Rana Ramdev Medico Private Limited | ₹49.13 Lakh (FY 2024) | -25.0% | Bangalore, Karnataka, India | |||
| Amglos Pharmaceutical Private Limitedthis company | ₹49.12 Lakh (FY 2024) | ₹62,901 | 1.3% | 9.0% | Ghaziabad, Uttar Pradesh, India | |
| Srijak Multisolutions Private Limited | ₹49.12 Lakh (FY 2025) | 270.0% | Varanasi, Uttar Pradesh, India | |||
| Jaybharti Mahila Kisan Producer Company Limited | ₹49.1 Lakh (FY 2024) | 461.0% | Ashta, Madhya Pradesh, India | |||
| Trilliant Retail Private Limited | ₹49.09 Lakh (FY 2019) | -31.0% | Chennai, Tamil Nadu, India | |||
| Comet Tie-Up Pvt.Ltd. | ₹49.07 Lakh (FY 2024) | 177.0% | Lucknow, Uttar Pradesh, India | |||
| Kothari Cotex Private Limited | ₹49.07 Lakh (FY 2025) | -69.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Amglos Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Amglos Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amglos Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amglos Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AASCA9746Q1ZE | Uttar Pradesh | Active | 01 Dec 2019 |
To see the full GST registrations and return filing status of Amglos Pharmaceutical Private Limited, buy the company report.
Recent activity
Amglos Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Chandni Sharma was appointed as Director on 25 Nov 2019.
Frequently asked questions
Amglos Pharmaceutical is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 November 2019 (7+ years old) and is registered under CIN U51909UP2019PTC123757.
Amglos Pharmaceutical has 2 current directors:
- Chandni Sharma - Director
- Garima Gautam - Director
The latest financial statements of Amglos Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Amglos Pharmaceutical is 09AASCA9746Q1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Amglos Pharmaceutical is U51909UP2019PTC123757. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amglos Pharmaceutical was incorporated on 25 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Amglos Pharmaceutical by revenue are DVM Life Sciences Private Limited, Nexgen Power Engitech Private Limited, Zware Mercantile Private Limited, Autopark India Motors Private Limited, Rana Ramdev Medico Private Limited and 5 more, all in the same principal business activity (retail trading).
Chandni Sharma was appointed as Director on 25 Nov 2019. Garima Gautam was appointed as Director on 25 Nov 2019.
The registered office of Amglos Pharmaceutical is at Kh No. 1319 Amar Vihar Behta Loni, Ghaziabad, Uttar Pradesh, India – 201102.
Amglos Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Amglos Pharmaceutical can be reached at its registered office: Kh No. 1319 Amar Vihar Behta Loni, Ghaziabad, Uttar Pradesh, India – 201102.